In a significant advancement for oncology healthcare, Utah Cancer Specialists (UCS) has established a collaboration with Canopy, a leader in Enterprise AI for cancer treatment. This new partnership aims to transform how care teams interact and monitor patients between their visits, enhancing the overall patient experience through the integration of cutting-edge technology.
The decision to partner with Canopy arises from UCS's need to upgrade outdated systems with a more effective, AI-native solution. With Canopy's innovative platform, UCS plans to implement programs focused on Remote Therapeutic Monitoring (RTM) and Care Management (CCM/PCM), essential in adapting to the complexities involved in cancer treatment.
Kyle Kitchen, UCS’s Chief Clinical Officer, emphasized, "It's crucial for our patients to stay connected with their care teams. Canopy's platform allows us to create a more patient-centric approach and significantly reduce administrative burdens that can hinder care delivery."
Canopy's AI-driven system supports practices in navigating the intricate demands of cancer care. It incorporates various functions, such as patient triage, call center operations, front office activities, referrals, and pharmacy management into a single platform. By embedding AI capabilities within existing workflows, the system promotes faster resolution of issues and minimizes manual labor, ultimately improving reimbursement sustainability for practices.
Founder and CEO of Canopy, Lavi Kwiatkowsky, echoed this sentiment by stating, "AI has a crucial role in supporting oncologists, but only when it seamlessly integrates into their ongoing operations. It's vital that the technology evolves collaboratively alongside the practices it serves. We are committed to maintaining that dynamic with UCS."
Canopy's platform has demonstrated substantial benefits in real-world oncology settings. Notable outcomes from studies reveal:
- - A 22% reduction in emergency room visits and hospitalizations per 100 patient months.
- - A 52% decrease in hospitalizations due to infections.
- - Significant estimated savings of $977,695 annually for every 1,000 patients affected by infection-related events.
- - Improvement in treatment adherence, with 22% to 45% of patients persisting with treatment three months post-initiation.
- - An impressive 88% of patients engaged at the six-month mark post-treatment.
- - Enhanced detection of toxicities associated with bispecific antibody therapies.
Additionally, care teams utilizing Canopy’s technology report remarkable efficiency gains:
- - An average resolution time of just 15 minutes for urgent symptom reports from patients.
- - A 93% increase in the resolution speed of patient requests compared to previous methods.
- - A fourfold boost in reimbursement from RTM and CCM programs.
Canopy is rapidly expanding its reach, with contracts in place with 10% of oncology providers across more than 500 sites in the U.S. This expansion signifies a growing recognition of the crucial role AI can play in modern healthcare practices.
About Canopy: As a frontrunner in Enterprise AI for Oncology, Canopy equips healthcare practices with a unified platform that facilitates care coordination and efficiency between patient visits. With over 2,000 oncology providers partnered across 500+ care locations nationally, Canopy helps prioritize and support patients needing attention while optimizing the management of care workflows and creating new revenue avenues. For further details, please visit
www.canopycare.us.
About Utah Cancer Specialists: UCS stands as Utah's largest community-based oncology and hematology practice, offering comprehensive medical oncology, hematology, radiation oncology, and imaging services. The team is proficient in managing a wide array of cancers, including rare types, and is deeply involved in clinical research efforts aimed at harnessing breakthrough laboratory advancements for better, less intrusive treatment modalities. More information about their services can be found at
utahcancer.com.